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Recent advances in the intellectual property 
landscape of filamentous fungi
Silvia Hüttner1,2* , Anton Johansson1, Paulo Gonçalves Teixeira1, Puck Achterberg1,3 and Ramkumar B. Nair1
Abstract 
For centuries, filamentous fungi have been used in the making of food and beverages, and for decades for the 
production of enzymes and pharmaceuticals. In the last decades, the intellectual property (IP) landscape for fungal 
technology has seen an ever increasing upward trend, introducing new and promising applications utilising fungi. 
In this review, we highlight fungi-related patent applications published during the last 5 years (2015–2020), identify 
the key players in each field, and analyse future trends. New developments in the field of fungal technology include 
the increased use of filamentous fungi as a food source (mycoprotein), using fungi as biodegradable materials, in 
wastewater treatment, in integrated biorefineries and as biological pest agents. Biotechnology companies in Europe 
and the US are currently leading when it comes to the number of patents in these areas, but Asian companies and 
research institutes, in particular in China, are becoming increasingly important players, for example in pesticide formu-
lation and agricultural practices.
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Introduction
Filamentous fungi
Fungi are eukaryotic organisms that have characteris-
tics of both plants and animals but are placed in a dis-
tinct kingdom [1]. Fungi in general can be microscopic 
to macroscopic, and include unicellular organisms, such 
as yeasts, and multicellular organisms, such as filamen-
tous fungi. Filamentous fungi grow as long, 2–10  μm 
thin filaments (hyphae) into intricate network structures 
(mycelium) that are observable to the naked eye and can 
grow to centimetre- to metre-scale. Filamentous fungi 
represent an incredibly rich and diverse group of species, 
with tens of thousands of fungal strains that have been 
identified, characterised, utilised and modified to this 
day. There is significant growth in the number of cata-
logued fungal strains, with an estimated 95% of fungal 
species estimated to be undescribed yet [2], and the sci-
entific community is building an increasingly vast body 
of knowledge around these complex and valuable organ-
isms. The large and growing interest in filamentous fungi 
mostly stems from the fact that their metabolic processes 
can be used to produce and refine a wide range of prod-
ucts and solutions [3] that create value for science, indus-
tries, and consumers.
Filamentous fungi, along with other microorganisms 
such as bacteria, yeast and algae, have been proven to be 
very useful for industrial applications [4]. Historically, 
their metabolites have created massive values in areas 
ranging from pharmaceuticals [5] to cosmetics [6] and 
commodity chemicals [7], and the production of these 
metabolites has had significant impact across the entire 
biotechnology spectrum. Starting with breakthrough 
developments of antibiotics in the early twentieth cen-
tury, filamentous fungi have since then been used for 
applications that include producing biological control 
agents, enzymes, alcoholic beverages, organic acids, food 
and feed [8, 9]. With the rapid developments in strain dis-
covery, strain engineering and industrial product devel-
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to be a key contributor in the creation of a biotechnol-
ogy-based future.
Filamentous fungi and intellectual property rights
As a result of these breakthrough solutions taking shape, 
activity in the intellectual property (IP) space is increas-
ing as well. As the value and potential of filamentous 
fungi become more and more established and recog-
nised, efforts to capture and control that value through 
the use of intellectual property rights (IPRs) have inten-
sified across the globe [10]. Patents are arguably the 
most important IPRs for protection solutions, and the 
landscape unveils a growing body of patents surround-
ing novel processes and products related to filamentous 
fungi. This is indeed a strong indicator that international 
markets are realising the great potential that these organ-
isms have, and that key industry players are doing what 
they can to secure value creation and value capturing 
through the use of IPRs.
Protecting filamentous fungi and other microorgan-
isms with patents and other IPRs is challenging for two 
reasons. The first reason is that inventions relating to 
biological material are, by their nature, much more dif-
ficult to disclose than inventions in other areas. Patent 
law requires that a patentable invention be disclosed in 
a manner elaborate and clear enough so that a person 
skilled in the art can carry it out. With inventions relating 
to microorganisms, such disclosure is usually impossi-
ble. The Budapest Treaty, first signed in 1977 and entered 
into force in 1980, attempts to circumvent this problem 
by allowing instead for depositing samples of biological 
material to recognised institutions [11, 12]. Thus, all pat-
enting procedures of new and modified strains of micro-
organisms, including filamentous and yeast-type fungi, 
follow the provisions of the treaty. The second reason is 
that much of the legislation around patenting of micro-
organisms is highly bureaucratic and difficult to comply 
with [13]. An example can be found in the Trade-Related 
Aspects of Intellectual Property Rights (TRIPS) agree-
ment, whose provisions are well-known among industry 
players as very challenging to understand and live up to. 
A range of other issues have been created as a result of 
the ratification of TRIPS, all of which deserve analysis 
and discussion, but for the scope of this report it is suf-
ficient to mention that many challenges are present.
Clearly, protecting technology surrounding filamen-
tous fungi with patents and other types of IPRs is not 
an entirely easy ordeal. To truly realise and capture the 
great potential value of filamentous fungi, these chal-
lenges need to be thoroughly understood and taken 
care of. Related to this fact is that any industrial player 
should be mindful and attentive of past and current 
trends within the patent landscape of filamentous fungi. 
Despite the clear importance of filamentous fungi in 
developing ground-breaking biotechnology, efforts to 
summarise the critical and current IPR trends around 
filamentous fungi is lacking. This report therefore sets 
out to provide a thorough analysis of the recent pat-
ent landscape surrounding filamentous fungi and its 
various (industrial) applications. In addition, we seek 
to identify the key global players in the most important 
markets, and to make predictions about developments 
within this technological area for the coming years.
Patent landscape
Before analysing more specific fields of application, we 
will discuss the general patent landscape regarding fila-
mentous fungi. First of all, it can be clearly seen that 
there has been a considerable increase in publications 
of patent families discussing filamentous fungi starting 
in 1990 (Figs. 1 and 2a). For the patent search and anal-
ysis the software Orbit Intelligence (Questel) was used 
(details in “Methods” section).
The top 5 players in terms of numbers of patents in 
the field of fungal technologies over the last 30  years 
were Novozymes (311), Dupont (289) incl. Danisco & 
Genencor, DSM (133), Meiji Holdings (44), and AIST 
(38)—International Institute of Advanced Industrial 
Science Technology. All are established biotechnol-
ogy institutions that provide biological solutions for 
a variety of applications. The major technology areas 
over the same time frame were the following: 37.6% 
biotechnology, 15.0% basic chemical materials, 10.9% 
food chemistry. The majority of the patents categorised 
as biotechnology were found within the subgroup of 
enzymes and microorganisms.
During the last 5  years the distribution of patent 
classification in the field has not changed much, with 
36.8% of patent applications being classified as belong-
ing to the domain of biotechnology, while 15.7% were 
classified as basic materials chemistry, and 10% as food 
chemistry. The biggest observable trend concerned 
the countries of origin of patent applications. Here, 
an increase in patent families originating from Asian 
countries (mostly China and Japan) was noticeable. The 
key players of the last five years were: Dupont (137) 
incl. Danisco & Genencor, Novozymes (99), DSM (57), 
Toray Industries (24) and Dalian Institute of Chemical 
Physics (23) (Fig. 2b).
In the following sections, we describe the patent 
landscape in seven different subfields. Selected pat-
ents do not represent a complete list of published 
inventions, but instead were chosen to give an over-
view of the trends in the field and highlight important 
developments.
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Food and feed
Fungi have been used all over the world for millennia 
to produce various fermented foods and beverages [14, 
15]. Traditional fermentation processes involving fungi 
and yeast are for example used to create soy sauce, miso, 
tempeh, “mould-cheeses” and beverages like beer, wine 
and spirits (Table  1). Mushrooms, the fruiting bodies 
of fungi, are of course also an important food, with the 
global mushroom market estimated to be worth over 
USD 42 billion [16]. However, in this study we did not 
include applications and inventions related specifically to 
mushrooms.
Because of the many challenges related to global sup-
ply and demand for food, biotechnology has become an 
increasingly important solution for creating ways to feed 
the world. More recently, during the last decades, dif-
ferent microorganisms such as bacteria, yeast and algae 
have been heavily researched for their ability to create 
various types of biomass and compounds that can be 
used in production of food and animal feed [17, 18], with 
filamentous fungi being no exception, as they can pro-
duce a variety of useful food ingredients like enzymes, 
fatty acids, flavouring, organic acids, pigments and vita-
mins (Table 2).
Within the area of food and feed applications, three 
main patenting sub-trends could be identified: produc-
tion of food additives, using fungi as the main ingredient 
in new food products and using fungi for production of 
animal feed. All patents mentioned in this section can be 
found in Table 3.
Looking at the patent landscape regarding food addi-
tives and filamentous fungi it could be seen that most 
patents relate to the production of enzymes or other 
compounds by either using a fungus as recombinant 
production host (i.e. inserting genes into its genome to 
produce new substances), or by using specific metabo-
lites or enzymes native to the fungus. Filamentous fungi 
are highly important for their ability to selectively pro-
duce certain compounds of interest than can be used 
for areas such as nutritional supplementation, dyeing, 
and texture improvement. To name just a few exam-
ples of this, the patent landscape revealed new meth-
ods for producing sweeteners like steviol (EP3063286, 
WO2019006244A1) and other flavouring agents like 
sesaminol (WO2018/056388), as well as special dietary 
proteins (CN110746494) and a range of vitamins and 
minerals. Even some enriched nutritional products that 
include the whole fungi biomass have been developed, 
such as an iron supplement made with Aspergillus ory-
zae (EP3462915) or fungi that are enriched in vitamin D 
through UV irradiation (US20180021405). When looking 
at proteins and enzymes as food additives, the patents 
focus mostly on ones that improve textures and process-
ability of materials, such as glucose oxidases for baking 
processes (EP3182829), xylanase to improve the stor-
age of crisps (EP2869701) or ice structuring proteins to 
improve the freezing process of foods (EP3302076).
Even though fermentation with filamentous fungi has 
been used in food production for a long time, there are 
still improvements to be made. Accordingly, there was 
a surprisingly high number of new patents that relate to 
traditional food products and traditional food production 
processes. Improvements include hydrolases to increase 
soy sauce production (JP2016136843A), pre-cultures for 
faster koji production (US20190159495) and tea fermen-
tation (CN107494809), removing off flavours in rice wine 
(KR20180055255), increased fermentable sugars in beer 
production (WO2019/067287) and better production 
Fig. 1 Heatmap of the top 30 organisations and their numbers of patent inventions (families) over time in the field of fungal technologies (for 
search terms, see “Methods” section)
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of tempeh and other fermented bean-based foods 
(JP2016123395, JP2019129802).
One area that has seen a noticeable increase in patent 
applications in the last years is the production of food 
products that contain biomass or proteins of filamentous 
fungi as a or the main ingredient. Often, the application 
of the fungi here is called mycoprotein or, if the target 
area is animal feed, single cell protein (SCP). So far, there 
are only a handful of players in this field, but the trend 
certainly points towards an increase in this segment. 
Fig. 2 Overview of the development of the fungal technology patent landscape. a Increase of patents regarding fungi-related technologies 
and products over time (left). b Top 30 organisations and the numbers of patent inventions (families) in the field of fungal technologies with a 
publication date after 2015-01-01
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The reasons for this are the high demands by consum-
ers for more variety in the vegetarian and vegan product 
segment (e.g. to have an alternative to soy), the general 
increase of vegetarian and vegan products on the market, 
as well as the increased knowledge about the nutritional 
advantages and benefits of fungi-based protein. Myco-
protein is becoming an increasingly popular alternative 
to meat and even to meat alternatives like soy and pea, 
due to a very favourable amino acid profile and texture. 
We also identified examples of inventions related to fur-
ther improving the attractiveness of filamentous fungi 
as a nutrient source by boosting the contents, ratios or 
availability of nutrients, as discussed below. One of the 
earliest patents in the area of mycoprotein were filed by 
Marlow Foods and describe production of what is now 
known as Quorn. Even though the original patents were 
filed in the 80ies (e.g. EP0804086), continuous improve-
ments and inventions have been made, such as different 
ways to bind the proteins together (EP3474685) or reduc-
ing RNA levels in the final product (WO2018/002581). 
Table 1 Overview of different fungal species in traditional 
food applications. Adapted from Hyde et al. [15]
Application Product Fungal species
Beverages Beer, rum, wine Saccharomyces cerevisae
Sake Aspergillus oryzae
Cheeses Roquefort, Blue cheese Penicillium roqueforti




Other food products Ang-Kak Monascus purpureus
Doenjang Aspergillus oryzae
Miso Aspergillus oryzae, A. sojae
Hamanatto Aspergillus oryzae
Oncom Neurospora intermedia, 
Rhizopus oligosporus




Table 2 Overview of some metabolites obtained from filamentous fungi and yeasts. Adapted from Copetti [18]
Ingredient Compound Producing fungus Application
Enzymes Amylase Aspergillus niger, A. oryzae Production of glucose syrup, bread improve-
ment, etc.
Invertase Saccharomyces cerevisiae, S. uvarium Soft-centred candies, artificial honeys, confec-
tioneries, liqueurs, etc.
Galactosidase Mortierella vinaceae Beet sugar refining
Lactase Aspergillus niger, A. oryzae, Kluyveromyces 
marxianus, K. fragilis
Production of lactose-free milk and dairy prod-
ucts, upgrading cheese whey
Pectins Aspergillus niger, Aspergillus spp. Juice clarification, improvement of grape juice 
yield, removing coffee mucilage, etc.
Proteases Aspergillus oryzae, Aspergillus spp. Bread improvement, chill proofing of beer, milk 
coagulation, meat tenderization, etc.
Fatty acids O3 and O6 Mortierella alpina, Saccharomyces cerevisiae, 
Candida lipolytica
Addition of polyunsaturated fat acids (bioactive 
compounds) to the composition of food and 
food products
Flavouring Blue cheese flavour Penicillium roqueforti Impress blue cheese flavour in food products
Bitter almond flavour Ischnoderma spp. Impress almond flavour in food products
Roselike odor Saccharomyces spp., Kluyveromyces spp. General food flavouring
Fruity, nutty, and fatty odor Candida lipolytica, Pichia ohmeri General food flavouring
Organic acids Citric acid Aspergillus niger, Candida lipolytica Soft drinks, jams, jellies, candies, frozen fruits, 
dairy products, wine, etc.
Gluconic acid Aspergillus niger Cleansing milk, beer and soft drinks bottles, bak-
ing products, etc.
Pigments and vitamins Beta-carotene Blakeslea trispora Orange-red food colorants, vitamin A precursor 
and antioxidant
Lycopene Blakeslea trispora Red food colorant and bioactive compound
Monascus pigments Monascus spp. Spice and yellow, orange and red food colorants 
in Asia, meet preservatives
Natural red Penicillium oxalicum Red food colorant
Riboflavin Ashbya gossypii Yellow colorant and B2 vitamin
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Table 3 Overview of selected patent families associated with food and feed
Patent number 
(one of the family)




 EP3063286 AT, AU, BE, CH, DE, DK, EP, ES, FR, GB, IE, JP, 
MX, NL, RU, SE, US, BR CA, CN, ID, IN
Conagen Inc. (2014, 2016) Recombinant production of steviol 
glycosides
 WO2019006244A1 AU, BR, CA, CN, EP, IN, KR, PCT WO Conagen Inc. (2018, 2019) Hydrolysis of steviol glycosides by beta-
glucosidase
 WO2018/056388 CN, JP, TW, PCT WO Suntory (2017, 2019) Method for production sesaminol or 
sesaminol glycoside
 CN110746494 CN Shenzhen Novojin Biotechnology (2019, 
2020)
A group of special dietary proteins
 EP3462915 AU, BR, CA, CN, EP, IN, JP, KR, MX, US Cura Global Health (bvi) Ltd. (2016, 2019) Process for forming iron enriched nutri-
tional products
 US20180021405 WO Entia Biosciences Inc. (2017, 2018) Nutritional approach to the control of 
anaemia, diabetes and other diseases or 
conditions and prevention of associ-
ated comorbid states with the use of 
ergothioneine
 EP3182829 EP, WO DSM IP Assets BV (2015, 2017) Combination of glucose oxidases for 
improvements in baking
 EP2869701 WO, AR DSM IP Assets BV (2013, 2015) Crisp baked products comprising xylanase
 EP3302076 AU, EP, MX, US, WO DSM IP Assets BV (2016, 2018) Use of ice structuring protein afp19 
expressed in filamentous fungal strains 
for preparing food
Traditional fermentation-related patents
 JP2016136843A JP Kikkoman Corp (2015, 2019) Filamentous-fungus mutant in which 
hydrolase activity is improved
 US20190159495 JP, US Yamasa Corp (2018, 2019) Method for short-time koji production 
using pre-cultured filamentous fungi
 CN107494809 CN Anhui Zhonghui Te (2017, 2017) Black tea yeast starter and preparation 
method thereof
 KR20180055255 KR RDA—Korea Rural Development Admin-
istration (2016, 2018)
Method for manufacturing rice wine 
with reduced heat flavor, and rice wine 
manufactured by same
 WO2019/067287 EP, US, PCT WO DuPont Nutrition Biosciences ApS (2018, 
2019)
Production of brewer’s wort having 
increased fermentable sugars
 JP2016123395 JP Akita Konno Shoten (2015, 2018) Method for producing tempeh fermenta-
tion product
 JP2019129802 JP Kikkoman Corp (2018, 2019) Bean body structure solubilized product-
containing food composition and 
process for producing same
Fungi as main ingredient
 EP0804086 Expired Marlow Foods Limited (1995, 1997) Texturised foodstuffs from gelled edible 
fungus and hydrocolloid mixture
 EP3474685 GB, EP, TW, US Marlow Foods Limited (2016, 2019) Foodstuff
 WO2018/002581 GB, TW, WO Marlow Foods Limited (2017, 2018) Edible fungus
 WO2019/121697 EP, PCT WO Lantmännen Energi (2018, 2019) Process for industrial production of food-
graded fungal biomass
 US20190373934 EP, US, PCT WO Emergy Inc. (2019, 2019) Edible compositions including fungal 
mycelium protein
 EP3464555 EP, WO Mycorena AB (2017, 2019) Process for edible filamentous fungi 
cultivation and its integration in conven-
tional sugar to ethanol production
 EP3080282 WO, CA, US, EP Lantmännen Energi (2014, 2016) Integration of first and second generation 
bioethanol processes
 EP3209789 AU, CN, EP, US, WO University of Strathclyde (2015, 2017) Bioprocesses for co-production of ethanol 
and mycoproteins
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In recent years, the landscape has diversified, with more 
actors starting to file patents in the sector, in particular 
companies and organisations from Sweden, the UK and 
the US. They differ mostly in the use of different edible 
fungal species; while Quorn-related patents typically 
only use Fusarium venenatum, others use Neurospora 
crassa (WO2019/121697, US20190373934) or Zygomy-
cete species (Rhizopus oligosporus, R. oryzae). We saw a 
clear indication that actors are moving to develop and 
protect more industrially focussed processes. Exam-
ples include patents that describe a possible integration 
of production of filamentous fungi for food (and feed) 
applications with bioethanol production (EP3464555, 
EP3080282, EP3209789). Furthermore, most patents 
describing mycoprotein production use a form of sub-
merged fermentation (WO2017/181085), but some 
actors developed solid-state or surface-growth fermenta-
tion (WO2019046480A1, US20200268031A1).
Patents related to animal feed are mostly focussed on 
improving the digestibility of feed for the animal (IPC 
code A23K+). Most of these patents are protected in 
China and an increase has been seen in the last couple of 
years. Interestingly, many of the patents in this category 
can also have applications for human food, but do not 
necessarily mention this in the patent, nor is the patent 
categorised in human food applications.
Many examples of new patents related to animal feed, 
as will be expanded in more detail further below, were 
enzyme-related patents, such as the production of man-
nanases (EP3385376) and xylanases (WO2020/009964), 
as well as enzymes that break down fish guano for aqua-
feed (CN106805002). Other areas were related to prepar-
ing functional feed additives by using fungal fermentation 
(CN108450656, CN109497259). Pet food is another area 
where IP regarding filamentous fungi has increased in 
the last years, either as supplements produced by fungi, 
or as the whole fungi biomass to produce vegetarian pet 
food (CN108719578).
Key players
Historically, food-related applications of filamentous 
fungi have mainly been developed within the world of 
academia, however nowadays the landscape is domi-
nated by established biotech companies which produce 
enzymes used in the food production. More specifi-
cally, of 324 identified relevant patent families in the 
field of food products, 38% were owned by the top 10 
organisations. The key players from the last five years 
were DuPont (47 patents), DSM (16), AB Enzymes 
(13), Novozymes (11), Toray Industries (10). Marlow 
Foods had seven patents solely related to meat alterna-




Countries Assignee (application date, 
publication date)
Title
 WO2017/181085 US, AU, BR, CA, CN, EP, IN, JP, KR, MX, SG, 
WO
Mycotechnology Inc. (2017, 2017) Methods for the production and use of 
myceliated high protein food composi-
tions
 WO2019046480A1 AU, CN, CA, WO, US, KR, EP, TW, IL, CO Sustainable Bioproducts Inc. (2018, 2019) Edible composition with filamentous fungi 
and bioreactor system for the cultivation 
thereof
 US20200268031A1 WO, US Sustainable Bioproducts Inc. (2020, 2020) Food materials comprising filamentous 
fungal particles and membrane bioreac-
tor design
Animal feed
 EP3385376 EP, PCT WO AB Enzymes Oy (2017, 2018) Fungal mannanases
 WO2020/009964 EP, PCT WO Dupont Nutrition Biosciences Aps (2019, 
2020)
Xylanase-containing feed additives for 
cereal-based animal feed
 CN106805002 CN Zhejiang Baihui Biological Technology 
(2016, 2017)
Ferment fish guano for aquarium fishes
 CN108450656 CN Hunan Weigufang Biotechnology (2016, 
2018)
Method for preparing functional feed 
additive by performing orientated fer-
mentation on Chinese herbal medicine 
residues
 CN109497259 CN Zhengzhou Green Agriculture (2018, 
2019)
Starter feed of sucking pig with disease-
resistant function
 CN108719578 CN CAF—Chinese Academy of Forestry 
(2018, 2018)
Complete vegetarian pet food and prepa-
ration method thereof using beneficial 
fungus mixed culture technique
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perspective, the majority of patents were filed in China, 
closely followed by Europe, the US and Japan. Patents 
originating from Asia heavily focussed on traditional 
fermentation products, such as those of Kikkoman and 
Yasama, while Europe and the US focussed on patents 
related to the protein shift towards mycoprotein as a 
complete food source.
Pharmaceuticals
The economic significance of filamentous fungi to 
the pharmaceutical industry cannot be overstated. 
Fungi have been widely exploited due to their capac-
ity of producing a wide range of valuable compounds. 
Antibiotics, small molecules that inhibit the growth of 
microorganisms, in particular bacteria, are probably 
the best-studied fungal secondary metabolites [19]. 
However, although over a thousand antibiotic sub-
stances have been discovered in the past decades, less 
than around a hundred have been granted permission 
by regulatory agencies to be used in humans and ani-
mals, due to their toxic and adverse effects [20]. Most 
currently available antibiotics of fungal origin are 
found within the Aspergillus and Penicillium groups. 
Other fungi-produced pharmaceuticals include immu-
nostimulants, anti-infectives, immunosuppressants and 
statins.
To identify the most important trends related to the 
production of antibiotics and other pharmaceuticals, 
we considered activities both within the healthcare sec-
tor, as well in sectors like agriculture and animal hus-
bandry. The contents of recently published patents 
revealed for example that the growth inhibitory activ-
ity of certain antibiotics can be used against agricultural 
pests such as nematodes, arthropods and other parasites 
(EP3058939). Other compounds related to agricultural 
use of pharmaceuticals included biological fertilisers 
(CN107828699) and pesticides (WO2017188049), as well 
as fungal extracts that fight bee colony collapse disorder 
(US9474776B2).
In the healthcare sector, patents describing fungal 
technology were found for diverse applications, from 
biomaterials for the treatment of wounds (EP3165233) 
to products inhibiting the growth of oral bacteria in 
humans (WO201965124). Most new inventions, how-
ever, were not related to native fungal compounds, but 
to compounds produced in fungi as a production host, 
and are therefore related to the optimisation of cultiva-
tion techniques by genetically engineering the fungus 
(see also “Fungi cultivation methods” section). These 
included the production of antibodies (WO2019/175477, 
CN109575130, CN110256557) and glycan-based anti-
body-drug conjugates (EP3426288, US2017036233), 
the improvement of the production system itself 
(EP3004145), or the transformation of compounds 
through fungal fermentation (EP3442553) (Table 4).
Key players
Overall, large organisations were not as prevalent in the 
pharmaceuticals field compared to other fields in this 
study. In the performed patent search, 23% of patents 
could be assigned to the top 10 organisations, the most 
prominent being Merck, Alder, DuPont, CNRS and 
Novozymes. While most of these are established biotech/
pharmaceutical companies, a lot of IP was generated 
by universities and research centres such as CNRS and 
Shandong University, both of which are also among the 
top 10.
(Bulk) chemicals
The production of bulk chemicals—such as low molec-
ular weight organic acids—by filamentous fungi has 
attracted considerable attention due to their industrial 
applications. The demand for sustainable alternatives to 
petroleum as a source of fuel and a precursor for chemi-
cals is high and has driven advancements in synthetic 
biology, genetic engineering and microbiology. Filamen-
tous fungi are natural producers of a variety of molecules 
with potential applications. In addition, some species are 
capable of a high production of organic acids (e.g. citric 
acid, AU2008223787B2, US20150232892A1), which are 
often used as food additives and cosmetic ingredients. 
Organic acids are fully biodegradable molecules and can 
also be used as chemical intermediates for the produc-
tion of biodegradable polymers. Furthermore, filamen-
tous fungi are used to produce dyes, artificial aromas and 
flavourings. Chemically speaking, these include a wide 
range of aromatic molecules, polypeptides, oligo- and 
polysaccharides and phenolic compounds (US9637763, 
EP2754716, CN107987183). An interesting feature of 
the literature around fungi-based production of organic 
acids, and also of the patents covering the same, is that 
it is often sharply focused on the ability to produce indi-
vidual compounds, and not so much on the general pro-
duction processes of the fungi.
The wide variety of applications of organic acids 
was well reflected in the patenting landscape of fila-
mentous fungi. Several patents disclosed novel meth-
ods for production and uses of C4-dicarboxylic acids 
(WO2018051837A1, US2013288321, EP2473600B1, 
US20150104543A1) which have the potential to create 
commercial value in several ways. Other patents dis-
closed fungi-based methods for production of oxalyl-
CoA, glyoxylate and glycolic acid (WO2019020870A, 
US9783809B2) and fumaric acid (WO2017110970A1). 
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We detected an increase in patents related to fungal 
production of itaconic acid over the last years. This acid 
has gained recent interest as a future bio-based platform 
chemical [21, 22] and efforts are being made to increase 
space–time yield and the fungal production system 
(EP2183367B1, WO2014142647A1, WO2017074533A1, 
WO2018037123A1, US10443077B2, CN105274153A). 
Other developments lie in the integration of different 
production processes and the use of low-cost raw mate-
rials (US20190360004A1). All patents mentioned in this 
section can be found in Table 5.
Key players
As with other trends described, major biotechnological 
industry players were prominent in this field as well, such 
as Novozymes and DSM. There were, however, organi-
sations who are less active in other use areas of filamen-
tous fungi that were present within this patenting space. 
Examples are companies such as RHO Renewables, KAO 
and Shonan Technology Center. On the academic side, 
we saw a strong presence of biology-oriented research 
institutions such as the Technical Research Centre of Fin-
land (VTT).
Enzymes
The advances in fungi and enzyme research have had 
fundamental implications for industrial biotechnology 
[23]. Filamentous fungi are natural producers of a vari-
ety of different enzymes and are excellent at secreting 
them into the culture medium. For that reason, they are 
often successfully used as a chassis for the development 
of recombinant production strains. Again, this area is 
indicative of the incredible versatility and flexibility 
that can be obtained by using filamentous fungi for the 
production of various compounds of interest, and we 
saw a very wide range of topics and inventions covered 
in the patent landscape of fungi-based enzyme produc-
tion (Table 6).
Many disclosed inventions related to the production of 
specific enzymes, in particular lignocellulolytic enzymes, and 
related compounds of interest, such as laccases (EP1799816, 
WO2012023021A1) xylanases (EP3099794), phytases, cellu-
lases (EP2766471, WO2019122520A1, WO2019219804A1, 
WO2016090474A1), amylases (EP2906692), mannanases 
(EP3385376) and lytic polysaccharide monooxygenases 
(LPMOs; WO2016142536A1) to give a few examples. As 
would be expected, these patents have diverse application 




Countries Assignee (application date, publication date) Title
EP3058939 JP, WO NAI Inc. (2014, 2016) Antiparasitic agent
CN107828699 CN Weifang Huabin Biotechnology (2017, 2018) Agricultural composite microbial agent and prepa-
ration method of same
WO2017188049 AR, CN, JP, KR, TW, WO Kumai Chemical Industry (2017, 2019) Microbial pesticide formulation composition, 
method for producing same, and method of 
using the same
US9474776B2 US, EP, AU, WO, CA, DK, ES Paul Edward Stamets (2015, 2016) Integrative fungal solutions for protecting bees
WO201965124 EP, PCT WO Ikeda Shokken (2018, 2019) Composition to inhibit proliferation of oral bacteria
EP3426288 US, AU, CA, CN, EP, IL, JP, 
KR, MX, SG, TW
Alder Biopharmaceuticals Inc. (2017, 2019) Anti-pacap antibodies and uses thereof
US20170362338 US Merck (2017, 2017) Glycan-based antibody-drug conjugates
EP3442553 EP CNRS—French National Centre for Scientific 
Research (2016, 2019)
Use of a Withania extract for the treatment of 
neuromuscular disease
EP3004145 US DTU—Technical University of Denmark (2014, 
2016)
Genetically modified filamentous fungi and uses 
thereof
WO2019/175477 EP, PCT WO VTT—Technical Research Centre of Finland (2019, 
2019)
A subunit vaccine against porcine post-weaning 
diarrhoea
CN109575130 CN Aituojin Bio Pharmaceutical (2018, 2019) Monoclonal antibody for detecting hpv18 e7 
protein as well as preparation and application of 
monoclonal antibody
CN110256557 CN Northeastern University of China (2019, 2019) Anti-bap31 single-domain antibody and applica-
tion thereof
EP3165233 EP Latvijas University (2015, 2017) Biomaterial for treatment of acute and chronic skin 
wounds
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areas, and there are clear connections to industries rang-
ing from pharma to food to pulp and paper. Competition 
between actors producing these enzymes can be high, as 
the patent landscape revealed several patent disputes and 
invalidity actions between some of the strongest companies 
working within the field. This is perhaps not entirely surpris-
ing, as this part of the market space is inhabited by organisa-
tions with high levels of IP sophistication.
The main fungal production hosts have not changed 
much in the last decades, and were also in the selected 
patents mostly limited to Trichoderma reesei and Asper-
gillus species.
In the area of processes for enzyme production, patents 
were heavily focused on the general ability and potential 
of filamentous fungi to produce enzymes for a vast vari-
ety of purposes. The patents related to this field will be 




Countries Assignee (application date, publication 
date)
Title
AU2008223787B2 WO, MY, AR Adcuram Nutrition Holding GmbH (2008, 
2013)
Process for the preparation of citric acid 
employing filamentous fungi in a culture 
medium comprising glycerol
US20150232892A1 US Battelle Memorial Institute Inc. (2015, 2015) Enhanced citric acid production in Aspergillus 
with inactivated asparagine-linked glycosyla-
tion protein 3 (alg3), and/or increased laea 
expression
US9637763 AU, CH, DE, EP, GB, IE, JP, KR, MX, 
NL, NZ, RU, US, ZA, BR, CA, 
CN, IN
Rho Renewables Inc. (2012, 2017) Recombinant production systems for aromatic 
molecules
EP2754716 CH, CN, DE, EP, FR, GB, IT, JP, US, IN Shonan Technology Center Inc. (2012, 2015) Method for producing useful metabolite from 
filamentous fungus
CN107987183 CN Zhejiang University of Technology (2017, 
2018)
Method for chitosan oligosaccharide extraction 
from filamentous fungi
WO2018051837A1 CN, JP, US, VN KAO (2017, 2018) Mutant filamentous fungus and method for 
producing C4-dicarboxylic acid using same
US2013288321 DK, MX, WO, US Novozymes Inc. (2013, 2013 abandoned) Methods for improved C4-dicarboxylic acid 
production in filamentous fungi
EP2473600B1 DK, MX, WO, Novozymes Inc. (2010, 2016) Methods for improving malic acid production 
in filamentous fungi
WO2019020870A US, WO, EP VTT—Technical Research Centre of Finland 
(2018, 2019)
Improved production of oxalyl-CoA, glyoxylate 
and/or glycolic acid
US9783809B2 FI, EP, US, WO, DK VTT—Technical Research Centre of Finland 
(2012, 2017)
Eukaryotic cell and method for producing 
glycolic acid
WO2016193540A1 WO VTT—Technical Research Centre of Finland 
(2016, 2016)
Direct conversion of sugars to glycolic acid
WO2017110970A1 CN, JP, WO, US KAO (2016, 2017) Method for producing organic acid
US20150104543A1 WO DSM IP Assets BV (2014, 2015) Organic acid production by fungal cells
EP2183367B1 EP, WP, US Dutch DNA Biotech BV (2008, 2019) Production of itaconic acid
WO2014142647A1 WO Wageningen University (2013, 2014) Fungal strains with improved citric acid and 
itaconic acid production
WO2017074533A1 WO Battelle Memorial Institute (2016, 2017) Enhanced itaconic acid production in Aspergil-
lus with increased laea expression
WO2018037123A1 WO, EP, CN, US Lesaffre Et Compagnie (2017, 2018) Improved production of itaconic acid
US10443077B2 CN, EP, WO, US DSM IP Assets BV (2016, 2019) Fermentation process for producing itaconic 
acid under nitrogen free conditions
CN105274153A CN Jiangnan University (2015, 2016) Method for increasing yield of itaconic acid 
produced by fermentation of Aspergillus 
terreus
US20190360004A1 DK, US, CA, WO, CN, BR, EP, ES DSM IP Assets BV (2019, 2019) Integrated process for coproducing alcohol 
and organic acid from lignocellulosic material
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discussed in more detail in “Fungi cultivation methods” 
section.
Key players
Among the most prominent developers of fungi-
based solutions for enzyme production is Novozymes, 
a leading Denmark-based biotechnology group. AB 
Enzymes stands out as a rising actor within the field, 
having filed several significant applications during the 
last few years. Other renowned names from the bio-
technology space, such as Dupont, DSM, Codexis and 
Toray Industries, appear in the records as well. Aca-
demia is of course also well represented, with reputed 
organisations such as the Technical University of Den-
mark (DTU), India’s Council of Scientific & Industrial 
Research, VTT and Nagakoa University of Technology 
showing up repeatedly.
Environmental technology
The domain of environmental technology holds a variety 
of inventions, with most patent inventions being asso-
ciated with treatment of water (wastewater, sewage or 
sludge) or biological processes for separation. There has 
been a significant increase in inventions in this technical 
domain in recent years.
Interestingly, the area of using filamentous fungi in 
wastewater treatment is predominantly protected in 
China. In most of these inventions, fungi are integrated 
in the solution either as biomats or microbial sludge 
(US20190316077, CN206886941U, CN109370943, 
CN109092048, WO2018/014037). However, some pat-
ents were identified where enzymes from filamentous 
fungi are used, such as cellulases (EP3219797) and amyl-
ases, to break up compounds in the waste stream. Recent 
patents also included examples of degrading solid waste 
and transforming it into something with more value 
(CN108219887, EP2576213). The mentioned patents can 
be found in Table 7.
Key players
Most of the patents we analysed that fall into the area of 
biological water treatment were filed and protected in 
China (around 70%). The key players were Asia-based 
universities such as Central South University, Beijing 
University of Technology and Hohai University. Cur-
rently most patents are coming from research-based 
institutions, as it is still such a recent field. Another rea-
son why the adoption by companies has not been as fast 
as in other segments is perhaps that it is not quite as 
straightforward to make money from wastewater treat-
ment as it is through production and sales of chemicals, 
enzymes or pharmaceuticals. However, it is expected that 
in the future more companies will enter this landscape 
due to governmental incentives, penalties for environ-
mental pollution and increasing value of clean produc-
tion processes.




Countries Assignee (application date, 
publication date)
Title
EP1799816B1 JP, EP, WO, CA, CN, MX, TA, MA AB Enzymes Oy (2005, 2015) Novel laccase enzyme and use thereof
WO2012023021A1 CN, WO, BR, DE Council of Scientific & Industrial Research 
(2010, 2012)
Method for obtaining laccase enzyme from 
Arthrographis sp.
EP3099794 US, AR, AU, BR, CA, CN, EP, KR DuPont Nutrition Biosciences ApS (2014, 
2016)
Compositions and methods comprising a 
xylanase enzyme variant
EP2766471 AT, AU, CA, CN, CZ, DE, DK, EP, ES, FI, FR, 
GB, HR, HU, IN, IT, NL, NO, PL, PT, RO, SE, 
SK, US, BR
IFP Energies Nouvelles IFPEN (2011, 2017) Process for the continuous production of 
cellulases by a filamentous fungus using 
a carbon substrate obtained from an acid 
pretreatment
WO2019122520A1 WO AB Enzymes Oy (2018, 2019) Variants of fungal cellulase
WO2019219804A1 WO DSM IP Assets BV (2019, 2019) Process for producing a polypeptide
WO2016090474A1 WO Concordia University (2015, 2016) Novel cell wall deconstruction enzymes of 
Chaetomium olivicolor, Acremonium ther-
mophilum, and Myceliophthora hinnulea, 
and uses thereof
EP2906692 WO, MX Danisco—Dupont (2013, 2015) Method of using alpha-amylase from Tal-
aromyces emersonii for saccharification
EP3385376 EP, WO AB Enzymes Oy (2017, 2018) Fungal mannanases
WO2016142536A1 EP, US, WO, BR, CN Genencor International BV (2016, 2016) Enzymatic activity of lytic polysaccharide 
monooxygenase
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Fungi cultivation methods
To keep up with the rapid developments within all 
aspects of filamentous fungi applications, the methods 
and tools for cultivation need to improve accordingly. It 
is clear from the patent landscape that companies and 
public actors are seeking new ways in which we grow 
and manage these interesting microorganisms. Differ-
ent needs sprout these solutions, but the common goals 
to improve fungal cultivation have to do with increases 
in titre, rate or yield (TRY) of the process in question, as 
well as the efficient genetic modification of the produc-
tion strain. Two main patenting sub-trends were identi-
fied: one that relates to novel cultivation techniques and 
molecular biology methods, and one that relates to physi-
cal equipment for improved production.
In the subcategory of novel cultivation techniques 
fall patents that deal with metabolic and genetic engi-
neering, as well as the ways that fungi are cultivated, 
maintained, manipulated and stored. Examples include 
methods for continuous production of filamentous fungi 
(FR3071507), innovative solutions for producing fungi 
pellets of extraordinary density (WO2018/221482), novel 
biomat formation (KR20180117131A) and changing the 
viscosity phenotype of the organism (EP2673290). Fur-
thermore, several novel processes have been disclosed 
in conjunction with the product patents described in the 
section below.
As mentioned above, inventions in the area are also 
focused on the ability and potential of filamentous 
fungi to produce enzymes for a vast variety of pur-
poses. In this regard, many patents describe methods for 
modifying the fungal strains themselves at a molecular 
level. Examples include, but are not limited to, methods 
for continuous enzyme production (FR3071507), gen-
eral genome editing applications using CRISPR-Cas9 
(JP2018525983A, US20190194692A1), regulating gene 
expression in fungi and improving protein production 
or secretion (EP2576793B1, US9499826B2, US9512415, 
JPWO2017170917A1, CN109661402A, JP2018504936A), 
and using genetically modified filamentous fungi for pro-
ducing various biosynthetic products (EP3004145).
In the area of cultivation equipment, the major-
ity of patent-protected inventions relates to physical 
tools. These include new vessels for efficient fermen-
tation of filamentous fungi (CN207062292), equip-
ment for mechanical control of filamentous fungi ball 
size (CN108893254) and devices for maintaining fun-
gal cultures (CN209002501U, CN109628275). In con-
trast to other microorganisms, filamentous fungi often 
form mycelial macrostructures during cultivation, and 
depending on the process this can be either a benefit or 
a challenge. Aside from aspiring to improve fungi culti-
vation in general, we interpret this apparent demand for 
improved hardware as an increasing interest in integrat-
ing fungal cultivation solutions into existing industrial 
infrastructure. All patents mentioned in this section can 
be found in Table 8.
Key players
There was not a particularly strong presence of the oth-
erwise dominating actors in this particular field, even 
though they were present (e.g. Novozymes, Dupont, 




Countries Assignee (application date, publication 
date)
Title
US20190316077 US, JP, SG, CN, CA, KR, BR, WO, EP, CN, AU Sustainable Bioproducts Inc. (2016, 2019) Filamentous fungal biomats, methods of 
their production and methods of their use
CN206886941U CN Jiangnan University (2017, 2018) Sludge dewatering system is taken care of in 
online fermentation of filamentous fungi
CN109370943 CN Hefei Huagai Biotechnology (2018, 2019) A kind of microbial deodorant and prepara-
tion method thereof suitable for sewage 
treatment
CN109092048 CN Wuhan Boyang Guangwu Technology 
(2018, 2018)
Microbiocidal deodorant
WO2018/014037 US, WO University of California (2017, 2018) Clarifying water and wastewater with fungal 
treatment/bioflocculation
EP3219797 JP, WO RIKEN (2015, 2017) Cellulase activator and method for sac-
charifying lignocellulosic biomass by using 
same
CN108219887 CN Shandong Zhongrong Biotechnology 
(2017, 2018)
Method for producing biomass fuel blocks 
from sludge of sewage plant
EP2576213 AU, CA, CN, IL, IN, KR, MX, NZ, UA, ZA, 
BR, JP, SG, US, WO
Xyleco (2011, 2016) Processing biomass
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KAO). Rising in this landscape was AB7 Industry. How-
ever, most inventions relating to cultivation methods and 
equipment came from within academia, with organisa-
tions such as Shandong University of Medical Sciences, 
Lingnan Normal Universitym, VTT and Jiangnan Uni-
versity appearing repeatedly.
Materials
A nascent field that is picking up momentum is the application 
of mycelium of filamentous fungi as a material. Pure, compos-
ite and cross-linked mycelium materials have been created, as 
well as polymers of mycelium and fungi-derived chitin–glu-
can films. A recent paper by Cerimi et al. [24] gives an over-
view of patents that cover the production or use of fungi as 
biomaterial between 2009 and 2018. Recent patents describe 
fungi biomaterials that include textiles (CN106758447B), 
insulations (US10407675B2, WO2018120823A1), packag-
ing (CN108249037, US20180148682), leather-like materials 
(CN102329512A), composite materials (US20190090436A1, 
US20130202855, US20190390156A1, US20190284307A1), 
as well as methods on how to achieve these materials 
(US20200196541A1, WO2020115690A1). See Table  9 for 
more details.
In most cases, the mycelium is grown into molds or as a 
biofilm, inactivated, dried and processed to become a stiff 
or elastic material. A variety of different fungal strains, 
mostly Basidiomycetes such as Pleurotus ostreatus and 
Ganoderma lucidum, were mentioned in the associated 
patents.
Key players
The recent patent landscape for fungi-based materials 
is still fairly small with only four main players, three of 
which are US-based companies: Ecovative (21 patents), 
Ford (9), Shenzhen Technical University (8) and Mycow-
orks Inc. (3).
Table 8 Overview of selected patent families associated with fungi cultivation method
Patent number (one 
of the family)




 FR3071507 FR AB7 Industry (2017, 2019) Continuous production of filamentous fungi
 WO2018/221482 US, WO, CN, JP KAO (2018, 2020) Method for producing filamentous fungal 
pellets
 KR20180117131A JP, CN, CA, WO, WP, CN, AU, TW, US Sustainable Bioproducts Inc. (2017, 2018) Biomat of filamentous fungi, its production 
method and its use
 EP2673290 AU, BE, CN, DE, DK, EP, FI, GB, HK, 
JP, KR, NL, US, BR, CA
DuPont—Danisco US Inc. (2012, 2016) Filamentous fungi having an altered viscosity 
phenotype
 JP2018525983A WO, CN, US, JP, EP Danisco Dupont (2016, 2018) Genome editing system and method of use
 US20190194692A1 WO, US, EP DSM IP Assets BV (2016, 2019) A CRISPR-Cas system for a filamentous fungal 
host cell
 EP2576793B1 US, EP, MX, ES, DK, WO, CN, CA, US VTT—Technical Research Centre of Finland 
(2011, 2017)
Method for improved protein production in 
filamentous fungi
 JPWO2017170917A1 CN, BR, US, CA, JP, AU, EP, WO, PH Toray Industries Inc. (2017, 2018) Protein production method
 CN109661402A CN, US, EP, BR, WO Danisco Dupont (2017, 2019) Protein production system of fungi
 JP2018504936A WO, KR, MX, JP, US, CN, EP, ZA Danisco Dupont (2016, 2018) Fungal strains and methods of use
 US9499826B2 DK, EP, WO, US VTT—Technical Research Centre of Finland 
(2010, 2016)
Production of proteins in filamentous fungi
 US9512415B2 WO, DK, EP, US VTT—Technical Research Centre of Finland 
(2011, 2016)
Method for protein production in filamen-
tous fungi
 EP3004145 WO DTU—Technical University of Denmark 
(2014, 2016)
Genetically modified filamentous fungi and 
uses thereof
Cultivation equipment
 CN207062292 CN Shandong Academy of Medical Sciences 
(2017, 2018)
A kind of filamentous fungi fermentation 
tank
 CN108893254 CN Yixing Boden Teco Industrial Equipment 
(2018, 2018)
Equipment for mechanically controlling sizes 
of filamentous fungi balls in fermenting 
process
 CN209002501U CN Lingnan Normal University (2018, 2019) Filamentous fungus mycelium culture device
 CN109628275 CN Shanghai Howsome Biotechnology (2019, 
2019)
Improved small culture device for filamen-
tous fungi and culture method thereof
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Future trends
Because of the constantly increasing demand for food, 
and the many challenges facing the food and feed indus-
tries, we believe that microbiological, and in particular 
fungal, solutions for the production of food products 
and nutrients will become ever more important in the 
future. While other microorganisms show great prom-
ise for rising up to the challenge as well, filamentous 
fungi have excellent prospects for assuming the role 
of the single most important source of microbial nutri-
tion. This is related not only to the already high degree 
of consumer acceptance, but also to the robustness, 
(substrate) versatility, and speed of metabolic processes 
of filamentous fungi, as well as their favourable nutrient 
composition and naturally fibrous texture. The number 
of mycoprotein-related patents is expected to rise, from 
both small companies as well as multi-national organisa-
tions. But also inventions related to supplements, colours 
and aromas from fungal sources will further increase in 
the future. With the incredible versatility of filamentous 
fungi, we will continue to find novel application areas 
within the entire value chains of the food industries.
When looking at the pharma industry, there has been 
a clear decreasing trend among both academic and cor-
porate organisations regarding antibiotics research. 
Novel antibiotic discovery has been stagnating for 
many years [25], and any newly created antibiotics are 
mere iterations of previous core concepts. The search 
for novel antibiotics is now considered a low-reward 
effort by research funding agencies. As for private play-
ers, the incentives for novel antibiotics research often do 
not match the effort required for development. Lack of 
interest comes not only from the high investment costs 
required, but also that, if discovered, novel antibiotics 
will only be prescribed as a last line of defence in order 
to prevent acquired resistance to these new drugs, gen-
erating rather low revenues for pharmaceutical compa-
nies. Instead, however, the recombinant production of 
pharmaceuticals in fungal production systems is stead-
ily increasing, in particular with the rise of personal-
ised medicine and antibody-focused treatments. With 
an efficient secretion system, and the ability to produce 
complex and glycosylated proteins and chemicals, fungi 
are well-suited as efficient production hosts, and genetic 
engineering tools will certainly make them even more 
efficient in the future.
The amount, as well as the types, of (bulk) chemicals 
produced by fungal fermentation will increase in the 
future, and IP will continually be generated even for tra-
ditional processes such as organic acid production. We 
see constant innovation with new products entering the 
market and enhanced microbes being used for improved 
production processes. The fermentation step to produce 
the chemicals is now in many cases a mature technology, 
and the main innovation lies in the bioengineering of the 
organisms.




Countries Assignee (application date, publication date) Title
CN106758447B CN Beijing Zhongke Aobei Supersonic Wave Tech Research 
Institute (2016, 2018)
A method that prepares textile fabrics with ultrasonic 
waves
US10407675B2 US Ecovative Design LLC (2017, 2017) Method of fermenting mycelium composite material
WO2018120823A1 WO Shenzen Technical University (2017, 2018) Fungus-based biomass fireproof material using rice straw 
as main material and preparation method thereof
CN108249037 Revoked Dongguan Hopeway Packaging Tech Co Ltd (2017, 2018) Production method for organic packaging material
US20180148682 US, MX, WO Mycoworks Inc. (2018, 2018) Molding system for fungal structures
CN102329512A CN Ford (2011, 2016) Production method for dehydrated mycelium elements 
for outfitting vehicle interiors
US20190090436A1 WO, US Ecovative Design LLC (2018, 2019) High density rigid molded body of composite mycologi-
cal material
US20190390156A1 US, WO Ecovative Design LLC (2019, 2019) Open-cell mycelium foam and method of making same
US20190284307A1 CA, WO, US Mycoworks Inc. (2019, 2019) Deacetylation and crosslinking of chitin and chitosan 
in fungal materials and their composites for tunable 
properties
US20200196541A1 WO, US Mycoworks Inc. (2019, 2020) Mycelium growth bed with perforation layer and related 
method for creating a uniform sheet of mycelium from 
a solid-state medium
WO2020115690A1 WO Mogu S.R.L. (2019, 2020) Method of producing fungal mats and materials made 
therefrom
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Similar to chemicals, despite a long history of enzyme 
production with filamentous fungi, it is still an impor-
tant topic of innovation today. Enzyme production has 
had a tremendous impact not only in technical indus-
tries, but also in healthcare and biochemical synthesis 
processes. The advancements of biotechnology in these 
fields pave the way towards lower production costs of 
enzymes, improved gene discovery methods and faster 
development of production hosts. The increased avail-
ability of optimised fungal enzyme production systems 
also increases their use in industries dealing with bulk 
and low value products. As a prime example, low enzyme 
production costs are a crucial part in making lignocellu-
lose fermentation processes for biofuel and greener bulk 
chemical production (biorefineries) economically viable 
and competitive. Furthermore, with the accessibility of 
technologies for enzyme discovery and “bench-to-mar-
ket” routines, we foresee the number of enzyme-related 
patents to steadily increase. This is expected to be popu-
lated mostly by large private players with access to high-
throughput pipelines for enzyme discovery and testing.
The IP landscape in fungi-related environmental tech-
nology is also expected to grow in the near future as 
the need for efficient and benign waste(water) treat-
ment becomes more and more crucial. Scarcity of water 
around the world will demand more advanced water and 
environmentally friendly treatment applications. Other 
important areas that demand solutions are more efficient 
resource use and protection of ecosystems from prob-
lematic eutrophication due to (over)use of fertilizers. 
Due to their versatile character filamentous fungi offer an 
excellent opportunity for solving these problems and can 
be regarded as crucial players in the circular economy 
[26]. We expect that more integrated processes, where 
filamentous fungi play a part in adding value to resource 
streams that are seen as waste, will be seen in upcoming 
patents.
Future developments in the field of fungal cultiva-
tion methods are more difficult to predict. The creation 
of IP for new equipment and techniques for cultivating 
microbes could logically follow the trend of fermentation 
technology developments in general. However, with the 
development of breakthrough gene engineering tech-
niques and increasingly permissive regulation when it 
comes to GMOs, biotechnology as a field is shifting from 
a traditional fermentation-technology focus to a more 
microbe-engineering focus, so it would not be surprising 
if IP creation in the field of cultivation equipment will be 
decreasing over time, while the amount of patents being 
filed related to metabolic and genetic engineering will 
increase.
Finally, in the field of fungal biomaterials, we expect 
an increase in IP generation over the next decade, as the 
need and desire for renewable and biodegradable mate-
rials, that replace petroleum-based products, increases. 
Fungal biomaterials will shape the future of material sci-
ences, design, fashion, architecture and other material 
applications.
Conclusions
To summarise, the ability of filamentous fungi to produce 
a plethora of different compounds has been responsi-
ble for their past and continued industrial importance. 
The key trends that we identified regarding the patent-
ing landscape in the last 5 years (2015–2020) are the use 
of filamentous fungi as a food source (mycoprotein) by 
a wider variety of players, the continued improvement 
of cultivation techniques mostly due to metabolic engi-
neering and new genetic engineering techniques, and 
the use of filamentous fungi biomass as biodegradable 
alternatives to petroleum-based materials. Furthermore, 
the use of fungi in environmental technology is increas-
ing, with China spearheading the inventions in this field, 
and filamentous fungi are also becoming an increasingly 
important part in pesticide formulation and agricultural 
practices. We will certainly see a further increase of IP 
being generated for filamentous fungi, since the need for 
green and sustainable technology in all areas of industry 
is increasing. With only a fraction of fungi characterised 
and still a lot to learn regarding their metabolism and 
production of secondary metabolites, the potential of 
these fascinating organisms has by far not yet reached its 
peak.
Methods
Most patents were searched and analysed by using Orbit 
Intelligence (v.1.9.8), a software provided by Questel. The 
patents were searched, not by individual record, but by 
invention-based families (FamPat). In addition, they were 
searched without a restriction on countries or regarding 
their legal status, hence patents that were lapsed, expired 
or revoked would also show up in the search. Initially a 
set of defined key words in the title or claims served as a 
basic set of search parameters. With or without a specifi-
cally set time limit focusing either on patents with a pub-
lication date from 2015-01-01 to 28-02-2020 or patents 
dating as far back as possible in the Orbit Intelligence 
database. Next, within these basic searches, we looked at 
specific technology domains as provided by the software 
based on International Patent Classification (IPC) and 
Cooperative Patent Classification (CPC) codes. In addi-
tion, a combination of the provided technical domains 
at IPC/CPC code was sometimes used to get a better 
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understanding. As an example, to search within the field 
of food chemistry in relation to animal feed, IPC: A23K+ 
was used.
The standard script that was used for the searches was:
("FILAMENTOUS" "FUNGI" OR "FILAMENTOUS" 
"FUNGUS" OR "FILAMENTOUS" "FUNGAL" OR "FILA-
MENTARY" "FUNGUS" OR "FILAMENTARY" "FUNGI" 
OR "MYCOPROTEIN" "FUNGI" OR "MYCOLOGICAL" 
"FUNGI" OR "MYCOLOGICAL" "FUNGUS" OR "MYCO-
LOGICAL" "FUNGAL" OR "ASPERGILLUS NIGER" OR 
"ASPERGILLUS ORYZAE" OR "RHIZOPUS OLIGOSPO-
RUS" OR "RHIZOPUS ORYZAE" OR "FUSARIUM 
VENENATUM" OR "MYCOPROTEIN" "FUNGUS" OR 
"MYCOPROTEIN" "FUNGAL" OR "FUNGI-BASED BIO-
MASS" OR "FUNGAL BIOMASS")/CLMS/TI.
The statistical analysis was performed by the Orbit 
Intelligence software, however additional rules were 
added (if necessary) to group assignees if they were 
from the same mother company (e.g. Danisco & 
Genencor are grouped with DuPont), or from the 
same company/institute but applied their patents with 
slightly different assignee names.  While these search 
and analysis techniques were used as the basis for the 
paper, it does not include all relevant patents in this 
field. There are additional patents that do not comply 
with the search words used but do describe a filamen-
tous fungi application. Hence, the paper discusses some 
patents that fall outside the search. It should also be 
mentioned that the patents in “basic” search were not 
filtered regarding their relevance nor were they vali-
dated, hence the search could still include patents that 
have the right ‘words’, but do not have anything to do 
with the usage of filamentous fungi. Furthermore, espe-
cially within the technical domain of pharmaceuticals 
patents, some feature inventions protecting against fila-
mentous fungi instead of using them.
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